English Website Article
Can Minoxidil-Free Hair Serums Deliver Comparable Results?
Hair-loss and scalp-care products have become one of the fastest-growing areas of functional hair care.For many consumers, minoxidil is the best-known topical ingredient associated with androgenetic hair loss. For beauty brands, however, there is growing interest in minoxidil-free scalp serums built around cosmetic actives such as Aminexil, Capixyl, Procapil and Redensyl.
This raises an obvious question:
Can a cosmetic hair serum deliver results comparable to minoxidil?
The answer is more nuanced than many marketing claims suggest.Some multi-active topical formulations have produced encouraging results in small clinical studies, including studies in which outcomes were comparable with or even numerically stronger than minoxidil groups. However, the overall evidence base for these cosmetic active systems is still much smaller than the evidence accumulated for topical minoxidil.Understanding this difference is important for both consumers and brands developing private label scalp-care products.
Why Is Minoxidil the Benchmark?
Topical minoxidil has been studied for decades.In a 48-week randomized, double-blind multicenter trial involving 393 men with androgenetic alopecia, 5% topical minoxidil produced significantly greater increases in non-vellus hair count than 2% minoxidil or placebo. That long history of controlled clinical research is one reason minoxidil is frequently used as the benchmark when newer scalp-care ingredients are studied.This does not mean every consumer needs a minoxidil product, nor does it mean cosmetic scalp serums have no value. It simply means that claims such as “equal to minoxidil” require much stronger evidence than most cosmetic actives currently have.
Aminexil and Kopexil: Are They Different Ingredients?
One point is often misunderstood.Aminexil and Kopexil are not two completely different actives.The U.S. FDA's substance database lists both Aminexil and Kopexil as names associated with Diaminopyrimidine Oxide.
This ingredient is widely used in scalp-care and anti-hair-fall product concepts.For brands, it can be positioned as part of a scalp serum active system, particularly in products focused on hair-root care and reducing the appearance of thinning.However, chemical or functional similarity to minoxidil does not automatically demonstrate equivalent clinical performance.For this reason, a more appropriate product-development approach is:
Aminexil / Diaminopyrimidine Oxide + complementary scalp-care actives
rather than marketing Aminexil as a direct cosmetic replacement proven to perform exactly like minoxidil.
Capixyl: Peptide + Botanical Scalp-Care Positioning
Capixyl is generally associated with a combination of:
Acetyl Tetrapeptide-3 + Biochanin A from red clover.
These ingredients are used in scalp-care products focused on hair anchoring, follicle environment and hair-density positioning.An interesting 24-week randomized, triple-blind trial studied a formulation containing Biochanin A, Acetyl Tetrapeptide-3 and ginseng extracts against 3% minoxidil.Thirty-two participants completed the study.
Terminal hair counts increased by approximately 8.3% in the botanical/peptide combination group and 8.7% in the minoxidil group, with no statistically significant difference between the groups.
This is promising, but there is an important limitation: The study did not test Capixyl alone.
It tested a multi-ingredient formula that also contained ginseng and other formulation components. So the study supports the potential of a multi-active scalp-care concept, not proof that Capixyl by itself is clinically equivalent to minoxidil.
Procapil: A Multi-Component Hair-Root Active
Procapil is another popular active complex used in hair-density and scalp-serum formulas.
It generally combines: Biotinyl-GHK, Apigenin and Oleanolic Acid.
These components have been studied for mechanisms related to hair anchoring, scalp condition and pathways associated with hair follicle miniaturization. A recent review of topical hair-loss alternatives includes Procapil among the cosmetic active systems with emerging clinical evidence, but also notes that much of the available research involves combination formulas rather than Procapil alone.
That distinction matters for product development. Instead of building a product around one “miracle ingredient,” brands can use Procapil as part of a broader multi-pathway scalp serum.
Redensyl + Capixyl + Procapil: The Most Interesting Combination
One of the most frequently discussed non-minoxidil combinations is:
Redensyl + Capixyl + Procapil, often shortened to RCP.
A 24-week comparative study enrolled 120 men with androgenetic alopecia, of whom 106 completed the study. Participants used either 5% topical minoxidil or the RCP combination twice daily. The study reported higher investigator-evaluation and photographic improvement scores in the RCP group. For example, global photographic improvement was reported in 88.9% of the RCP group compared with 60% of the minoxidil group.
At first glance, these figures look impressive. But brands should interpret them carefully. This study tested three active complexes together, so it cannot tell us whether Redensyl, Capixyl or Procapil was responsible for the result.
The study is also much smaller than the body of evidence available for minoxidil, and this research area still needs larger, independently replicated trials.
So the responsible conclusion is: Multi-active cosmetic scalp-serum combinations may have meaningful potential, but current evidence does not justify saying that all such formulas are proven replacements for minoxidil.
Is a Multi-Active Formula More Interesting Than a Single Active?
For cosmetic product development, often yes. Hair thinning is not influenced by only one biological pathway. That is why modern scalp serums increasingly combine different categories of ingredients.
Redensyl for hair-density positioning,and complementary ingredients such as peptides, caffeine, panthenol or botanical extracts for broader scalp-care support. This creates a much more differentiated product concept than simply adding one fashionable ingredient to a basic serum.
Can a Minoxidil-Free Serum Really Be “As Good as Minoxidil”?
The most accurate answer today is:
Some formulations have shown comparable or encouraging outcomes in individual studies, but the evidence is not strong enough to treat all minoxidil-free cosmetic serums as clinically equivalent to minoxidil.
Minoxidil benefits from a much larger and longer-established evidence base. By contrast, newer cosmetic actives often rely on: small trials, proof-of-concept research, ingredient-supplier studies or combination formulas.That does not make them useless.It simply means beauty brands should market them differently.
Instead of claiming:
“Works exactly like minoxidil”
a better positioning would be:
“Multi-active scalp serum developed for hair density, hair-root care and healthier-looking scalp conditions.”
This is both more scientifically responsible and more suitable for cosmetic product positioning.
Developing a Minoxidil-Free Scalp Serum for Your Brand
For brands entering the scalp-care market, the biggest opportunity may not be finding a single ingredient to “replace minoxidil.” The stronger strategy is to develop a differentiated multi-active scalp serum system.
Danlan Beauty supports OEM/ODM and private label development of scalp serum and functional hair-care products. Formula concepts can be developed around active systems such as: Aminexil / Diaminopyrimidine Oxide, Capixyl, Procapil, Redensyl, peptides, caffeine and selected botanical scalp-care ingredients.
Customization can include active combinations, serum texture, fragrance, applicator design, scalp-friendly sensory profile, bottle packaging and private label artwork.
The final formulation and claims should always be reviewed according to the target market and applicable cosmetic or drug regulations.
If you are developing a private label scalp serum or anti-hair-fall hair care line, Danlan Beauty can support formula development, sampling, packaging and OEM/ODM manufacturing.